Detailed Mechanism Funding and Narrative

Years of mechanism: 2016 2017 2018 2019 2020

Details for Mechanism ID: 18170
Country/Region: Tanzania
Year: 2018
Main Partner: Ministry of Health and Social Welfare - Tanzania
Main Partner Program: NA
Organizational Type: Host Country Government Agency
Funding Agency: HHS/CDC
Total Funding: $412,432 Additional Pipeline Funding: $5,387,310

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $4,340
Care: Orphans and Vulnerable Children (HKID) $0
Care: TB/HIV (HVTB) $37,200
Care: Pediatric Care and Support (PDCS) $3,100
Laboratory Infrastructure (HLAB) $48,138
Strategic Information (HVSI) $73,712
Health Systems Strengthening (OHSS) $28,582
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $200,000
Biomedical Prevention: Blood Safety (HMBL) $0
Biomedical Prevention: Injection Safety (HMIN) $0
Sexual Prevention: Abstinence/Be Faithful (HVAB) $0
Testing: HIV Testing and Counseling (HVCT) $4,340
Sexual Prevention: Other Sexual Prevention (HVOP) $0
Prevention: Injecting and Non-Injecting Drug Use (IDUP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: ARV Drugs (HTXD) $0
Treatment: Adult Treatment (HTXS) $9,920
Treatment: Pediatric Treatment (PDTX) $3,100
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST 25-29, Female, Negative 2019 1,576
HTS_TST 25-29, Male, Negative 2019 3,298
HTS_TST 30-34, Female, Negative 2019 1,576
HTS_TST 30-34, Male, Negative 2019 3,298
HTS_TST 35-39, Female, Negative 2019 1,576
HTS_TST 35-39, Male, Negative 2019 3,298
HTS_TST 40-49, Female, Negative 2019 1,576
HTS_TST 40-49, Male, Negative 2019 3,298
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2019 28,872
HTS_TST Service Delivery Point (Facility) TB: <1, Negative 2019 23
HTS_TST Service Delivery Point (Facility) TB: 1-9, Negative 2019 472
HTS_TST Service Delivery Point (Facility) TB: 10-14, Female, Negative 2019 109
HTS_TST Service Delivery Point (Facility) TB: 10-14, Male, Negative 2019 74
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2019 143
HTS_TST Service Delivery Point (Facility) TB: 15-19, Male, Negative 2019 139
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2019 407
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2019 642
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2019 590
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2019 832
HTS_TST_POS 25-29, Female, Positive 2019 405
HTS_TST_POS 25-29, Male, Positive 2019 900
HTS_TST_POS 30-34, Female, Positive 2019 405
HTS_TST_POS 30-34, Male, Positive 2019 900
HTS_TST_POS 35-39, Female, Positive 2019 405
HTS_TST_POS 35-39, Male, Positive 2019 900
HTS_TST_POS 40-49, Female, Positive 2019 405
HTS_TST_POS 40-49, Male, Positive 2019 900
HTS_TST_POS Service Delivery Point (Facility) TB: 1-9, Positive 2019 66
HTS_TST_POS Service Delivery Point (Facility) TB: 10-14, Female, Positive 2019 70
HTS_TST_POS Service Delivery Point (Facility) TB: 10-14, Male, Positive 2019 19
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Female, Positive 2019 74
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Male, Positive 2019 35
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2019 105
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Male, Positive 2019 34
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Female, Positive 2019 176
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Male, Positive 2019 146
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 487
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 4,220
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 1,135
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 5,800
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2019 11,642
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 1,892
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 11,086
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 3,910
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 18,411
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2019 35,351
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2019 35,356
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 1,892
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 11,088
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 3,913
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 18,411